Greetings from Freyr China
Freyr is a leading Regulatory solutions provider offering comprehensive services to life sciences firms across the regulatory spectrum. With a robust presence spanning over 120 countries, we facilitate the "local to Global" journey for life sciences companies.
In China, Freyr China plays a pivotal role in assisting companies with Drug registration in China under the National Medical Products Administration (NMPA). Our services encompass Regulatory Strategy formulation, Market Intelligence, In-country representation, Post-Market Surveillance (PMS) functions, and more. Additionally, we provide cutting-edge Regulatory software solutions tailored to streamline the entire NMPA registration life cycle covering everything from the China new drug approval process to China generic drug approval process.
Global Presence in
25+ Countries
2500+
Inhouse Regulatory
Experts & Growing
Support in
120+ Countries
2100+ Global
clients & growing
Corporate Movie
Freyr Agentic Fleet
Via: Variation Identification Agent
The agentic intelligence layer for post-approval change management. Turn complex regulatory changes into clear, submission-ready decisions in minutes, simplifying post-approval variation assessment with speed, confidence, and full traceability.
Ria: Regulatory Impact Assessment Agent
Turn regulatory change into actionable impact assessment. Discover relevant regulatory developments, understand what they mean for your organization, and generate structured, traceable impact assessments through one intelligent workflow.
